TW200740769A - Novel process - Google Patents

Novel process

Info

Publication number
TW200740769A
TW200740769A TW096107514A TW96107514A TW200740769A TW 200740769 A TW200740769 A TW 200740769A TW 096107514 A TW096107514 A TW 096107514A TW 96107514 A TW96107514 A TW 96107514A TW 200740769 A TW200740769 A TW 200740769A
Authority
TW
Taiwan
Prior art keywords
novel process
hydantoin
specified
preparation
disclosed
Prior art date
Application number
TW096107514A
Other languages
English (en)
Inventor
Philip Cornwall
Daniel Horner
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of TW200740769A publication Critical patent/TW200740769A/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/76Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
TW096107514A 2006-03-16 2007-03-05 Novel process TW200740769A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78289206P 2006-03-16 2006-03-16

Publications (1)

Publication Number Publication Date
TW200740769A true TW200740769A (en) 2007-11-01

Family

ID=38509760

Family Applications (1)

Application Number Title Priority Date Filing Date
TW096107514A TW200740769A (en) 2006-03-16 2007-03-05 Novel process

Country Status (13)

Country Link
US (1) US7772403B2 (zh)
EP (1) EP1999115A4 (zh)
JP (1) JP2009530273A (zh)
KR (1) KR20080100260A (zh)
CN (1) CN101405273A (zh)
AU (1) AU2007225476A1 (zh)
BR (1) BRPI0709597A2 (zh)
CA (1) CA2644016A1 (zh)
IL (1) IL193677A0 (zh)
NO (1) NO20084290L (zh)
TW (1) TW200740769A (zh)
WO (1) WO2007106021A1 (zh)
ZA (1) ZA200807399B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0100902D0 (sv) 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
SE0202539D0 (sv) 2002-08-27 2002-08-27 Astrazeneca Ab Compounds
SE0401762D0 (sv) 2004-07-05 2004-07-05 Astrazeneca Ab Novel compounds
US7648992B2 (en) * 2004-07-05 2010-01-19 Astrazeneca Ab Hydantoin derivatives for the treatment of obstructive airway diseases
SE0403086D0 (sv) * 2004-12-17 2004-12-17 Astrazeneca Ab Compounds
SE0403085D0 (sv) * 2004-12-17 2004-12-17 Astrazeneca Ab Novel componds
TW200740769A (en) 2006-03-16 2007-11-01 Astrazeneca Ab Novel process
TW200831488A (en) * 2006-11-29 2008-08-01 Astrazeneca Ab Novel compounds

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3529019A (en) 1968-04-23 1970-09-15 Colgate Palmolive Co Alkylaryloxy alanines
US6339101B1 (en) 1998-08-14 2002-01-15 Gpi Nil Holdings, Inc. N-linked sulfonamides of N-heterocyclic carboxylic acids or isosteres for vision and memory disorders
SE0100902D0 (sv) 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
MXPA03008180A (es) 2001-03-15 2003-12-12 Astrazeneca Ab Inhibidores de metaloproteinasa.
SE0100903D0 (sv) 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
JP2004535411A (ja) 2001-05-25 2004-11-25 ブリストルーマイヤーズ スクイブ カンパニー マトリックスメタロプロテナーゼ及び/またはTNF−α転換酵素(TACE)の阻害剤としてのヒダントイン及び関連複素環化合物
SE0103710D0 (sv) 2001-11-07 2001-11-07 Astrazeneca Ab Compounds
TWI319387B (en) 2002-04-05 2010-01-11 Astrazeneca Ab Benzamide derivatives
SE0202539D0 (sv) 2002-08-27 2002-08-27 Astrazeneca Ab Compounds
SE0202693D0 (sv) 2002-09-11 2002-09-11 Astrazeneca Ab Compounds
GB0221246D0 (en) 2002-09-13 2002-10-23 Astrazeneca Ab Compounds
GB0221250D0 (en) * 2002-09-13 2002-10-23 Astrazeneca Ab Compounds
SE0401762D0 (sv) 2004-07-05 2004-07-05 Astrazeneca Ab Novel compounds
SE0401763D0 (sv) 2004-07-05 2004-07-05 Astrazeneca Ab Compounds
US7648992B2 (en) 2004-07-05 2010-01-19 Astrazeneca Ab Hydantoin derivatives for the treatment of obstructive airway diseases
SE0403086D0 (sv) 2004-12-17 2004-12-17 Astrazeneca Ab Compounds
SE0403085D0 (sv) 2004-12-17 2004-12-17 Astrazeneca Ab Novel componds
GB0501146D0 (en) 2005-01-20 2005-02-23 Astrazeneca Ab Novel benzamide derivatives
TW200740769A (en) 2006-03-16 2007-11-01 Astrazeneca Ab Novel process
TW200800954A (en) 2006-03-16 2008-01-01 Astrazeneca Ab Novel crystal modifications
TW200831488A (en) 2006-11-29 2008-08-01 Astrazeneca Ab Novel compounds

Also Published As

Publication number Publication date
CA2644016A1 (en) 2007-09-20
IL193677A0 (en) 2009-05-04
CN101405273A (zh) 2009-04-08
KR20080100260A (ko) 2008-11-14
EP1999115A1 (en) 2008-12-10
AU2007225476A1 (en) 2007-09-20
US7772403B2 (en) 2010-08-10
JP2009530273A (ja) 2009-08-27
EP1999115A4 (en) 2010-09-01
BRPI0709597A2 (pt) 2011-07-19
NO20084290L (no) 2008-12-10
WO2007106021A1 (en) 2007-09-20
US20090054659A1 (en) 2009-02-26
ZA200807399B (en) 2009-09-30

Similar Documents

Publication Publication Date Title
WO2007015017A3 (fr) Nouveaux derives de polyquinoleines et leur utilisation therapeutique
TW200617019A (en) A process for the preparation of 7α-alkylated 19-norsteroids
MY147732A (en) Process for the preparation of 2-substituted-5- (1-alkylthio) alkylpyridines
TW200740769A (en) Novel process
TW200720246A (en) Novel process for the preparation of acid chlorides
WO2008079787A8 (en) Glucokinase activators
WO2007093627A3 (de) Biozide zusammensetzung
TW200634018A (en) Azolopyrimidine-based inhibitors of dipeptidyl peptidase IV and uses
MX2009003382A (es) Derivados de sulfonamidas sustituidos.
TW200619205A (en) A method for preparing irbesartan and intermediates thereof
UA97806C2 (ru) Бензиламины, способ их получения и их применения в качестве противовоспалительных средств
MX2009008660A (es) Metodo para la preparacion de derivados de trifenilbuteno terapeuticamente valiosos.
TW200728310A (en) Process for the preparation of ferri-succinylcasein
TW200738649A (en) Calcilytic compounds
WO2009074741A3 (fr) Nouveau procede de synthese du ranelate de strontium et de ses hydrates
MY146671A (en) Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents
TW200738704A (en) New process for the production of tiotropium salts
TW200621703A (en) Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
TN2009000536A1 (en) Novel herbicides
UA87710C2 (ru) Способ получения производных [1,4,5]-оксадиазепина
TW200613308A (en) Cyclobutanetetracarboxylate compound and preparation method thereof
MX2009006479A (es) Derivados de hemicelulosa y estructuras que los emplean.
WO2008021385A3 (en) Processes for preparing intermediates of pemetrexed
WO2007143152A3 (en) Preparation of (s)-pregabalin-nitrile
WO2008015133A3 (en) Process for preparing amidrazones